Brought to you by 
Pfizer takes option to NO compounds from NicOx; concludes
07 Aug 2009
Executive Summary
NicOx SA (nitric oxide-donating drugs) has signed an agreement with Pfizer for the development and potential licensing of early-stage NO compounds in an undisclosed indication.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Concluded
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com